Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.31 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | GMNN | O75496 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | BLM | P54132 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | SGMS1 | Q86VZ5 | 1/20 | 0.31 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29885718 | 1.00 | ALDH1A1 (0.44) | ALDH1A1MAPTCA12GMNNCA1 | |
| SCHEMBL27526921 | 1.00 | ALDH1A1 (0.44) | ALDH1A1MAPTCA12GMNNCA1 | |
| SCHEMBL2724740 | 1.00 | ALDH1A1 (0.44) | ALDH1A1MAPTCA12GMNNCA1 | |
| SCHEMBL29886257 | 1.00 | ALDH1A1 (0.44) | ALDH1A1MAPTCA12GMNNCA1 | |
| SCHEMBL15454179 | 1.00 | ALDH1A1 (0.44) | ALDH1A1MAPTCA12GMNNCA1 | |
| Methane SCHEMBL11881987 | 0.97 | ALDH1A1 (0.41) | ALDH1A1MAPTCA12GMNNCA1 | |
| SCHEMBL30595060 | 0.97 | ALDH1A1 (0.41) | ALDH1A1MAPTCA12GMNNCA1 | |
| Barium SCHEMBL29897735 | 0.97 | ALDH1A1 (0.41) | ALDH1A1MAPTCA12GMNNCA1 | |
| SCHEMBL3003480 | 0.97 | ALDH1A1 (0.38) | ALDH1A1MAPTCA12GMNNCA1 | |
| SCHEMBL12475384 | 0.97 | ALDH1A1 (0.47) | ALDH1A1HSD11B1HSD11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 438 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3730590-B1 | LIQUID CRYSTAL MEDIA WITH HOMEOTROPIC ALIGNMENT | MERCK PATENT GMBH (DE) | 2025-12-24 | — | — | EP | claimed |
| US-12350381-B2 | Nanoparticles containing cellular membrane and uses thereof | ARYTHA BIOSCIENCES, LLC (US) | 2025-07-08 | — | — | US | claimed |
| US-12318481-B2 | Immune stimulating micelle composition | DANMARKS TEKNISKE UNIVERSITET (DK) | 2025-06-03 | — | — | US | claimed |
| US-20240197759-A1 | IMMUNE STIMULATING NANOPARTICLE COMPOSITION | MONTA BIOSCIENCES APS (DK) | 2024-06-20 | — | — | US | claimed |
| US-20230365995-A1 | LIPID NANOPARTICLE COMPOSITIONS | PRECISION BIOSCIENCES, INC. (US) | 2023-11-16 | — | — | US | claimed |
| US-20230346948-A1 | Lipid conjugated peptide inhibitors of PICK1 | UNIVERSITY OF COPENHAGEN (DK) | 2023-11-02 | — | — | US | claimed |
| US-11739066-B2 | Method for fluoroalkylation of enamines | ARXADA AG (CH) | 2023-08-29 | — | — | US | claimed |
| EP-4114524-A1 | LIPID CONJUGATED PEPTIDE INHIBITORS OF PICK1 | University of Copenhagen (DK) | 2023-01-11 | — | — | EP | claimed |
| US-20220362162-A1 | NANOPARTICLES CONTAINING CELLULAR MEMBRANE AND USES THEREOF | ARYTHA BIOSCIENCES, LLC (US) | 2022-11-17 | — | — | US | claimed |
| US-20220354789-A1 | IMMUNE STIMULATING MICELLE COMPOSITION | DANMARKS TEKNISKE UNIVERSITET (DK) | 2022-11-10 | — | — | US | claimed |
| CN-102811730-A | Methods for the use of progestogen as a glucocorticoid sensitizer | DU TAO | 2012-12-05 | — | — | CN | claimed |
| US-20110262502-A1 | PULMONARY DELIVERY OF 17-HYDROXYPROGESTERONE CAPROATE (17-HPC) | Prairie Pharmaceuticals LLC (US) | 2011-10-27 | — | — | US | claimed |
| WO-2011097571-A2 | METHODS FOR THE USE OF PROGESTOGEN AS A GLUCOCORTICOID SENSITIZER | PRAIRIE PHARMACEUTICALS, LLC (US) | 2011-08-11 | — | — | WO | claimed |
| US-20110195031-A1 | METHODS FOR THE USE OF PROGESTOGEN AS A GLUCOCORTICOID SENSITIZER | PRAIRIE PHARMACEUTICALS, LLC (US) | 2011-08-11 | — | — | US | claimed |
| US-20100204146-A1 | Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women | PREGLEM S.A. (CH) | 2010-08-12 | — | — | US | claimed |
| EP-2207544-A2 | TREATMENT OF OESTROGEN DEPENDANT CONDITIONS IN PRE-MENOPAUSAL WOMEN | PregLem S.A. (CH) | 2010-07-21 | — | — | EP | claimed |
| WO-2009037539-A2 | TREATMENT OF OESTROGEN DEPENDANT CONDITIONS IN PRE-MENOPAUSAL WOMEN | PREGLEM S.A. (CH) | 2009-03-26 | — | — | WO | claimed |
| US-6977250-B2 | Prevention of ovarian cancer by administration of progestin products | NEW LIFE PHARMACEUTICALS INC. (US) | 2005-12-20 | — | — | US | claimed |
| US-4780461-A | ANTIGESTAGENS | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-10-25 | — | — | US | claimed |
| EP-0129499-B1 | 13-ALPHA-ALKYL GONANES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1987-12-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12318481-B2 | Immune stimulating micelle composition | TLR7, TLR9, TLR1 | ALDH1A1 4760/4885MAPT 2717/4885CA12 3787/4885 |
| US-20220354789-A1 | IMMUNE STIMULATING MICELLE COMPOSITION | TLR7, TLR9, TLR1 | ALDH1A1 4760/4885MAPT 2717/4885CA12 3787/4885 |
| US-20240197759-A1 | IMMUNE STIMULATING NANOPARTICLE COMPOSITION | TLR7, TLR9, TLR5 | ALDH1A1 4189/4885MAPT 2525/4885CA12 4269/4885 |
| US-20100204146-A1 | Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women | STS, CYP19A1, SHBG | ALDH1A1 3380/4885MAPT 4645/4885CA12 1480/4885 |
| US-20230346948-A1 | Lipid conjugated peptide inhibitors of PICK1 | PEBP1, DAB2IP, PDCD6IP | ALDH1A1 4699/4885MAPT 842/4885CA12 4660/4885 |
| US-11739066-B2 | Method for fluoroalkylation of enamines | HNMT, PNMT, INMT | ALDH1A1 495/4885MAPT 3997/4885CA12 2554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.